Comparison of efficacy of alpha-glucosidase inhibitors in combination with dipeptidyl-peptidase-4 inhibitor (alogliptin) by continuous glucose monitoring between type 2 diabetic patients
Not Applicable
- Conditions
- type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000013135
- Lead Sponsor
- niversity of Occupational and Environmental Health, Japan, First Department of Internal Medicine, School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Patients using insulin therapy, those who were or may have been pregnant, and those with severe liver dysfunction (AST and ALT: 3 times the normal levels) were excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method